Cellular Senescence in the Cardiovascular System: Molecular Mechanisms, Pathophysiology, and Senotherapeutic Interventions
Beata Franczyk1, Anna Bajer1,#, Anna Bulicz1,#, Mikołaj Grabarczyk1,#, Paulina Jakubowska1,#, Katarzyna Krawiranda1,#, Natalia Kustosik1,#, Przemysław Kuzar1,#, Klaudia Leszto1,#, Maja Mejza1,#, Weronika Mstowska1,#, Jacek Rysz2, Ewelina Młynarska1,*
BIOCELL, Vol.50, No.7, 2026, DOI:10.32604/biocell.2026.075767
- 29 June 2026
(This article belongs to the Special Issue: Cellular Senescence in Health and Disease)
Abstract Cellular senescence and the Senescence-Associated Secretory Phenotype (SASP) play both physiological and pathological roles in the cardiovascular system. While transient senescence aids regeneration, chronic accumulation of senescent cells promotes endothelial dysfunction, arterial stiffening, and maladaptive cardiac remodeling. This review elucidates the pivotal role of the immune system in senescent cell clearance and explores how immunosenescence drives systemic low-grade inflammation. Significant emphasis is placed on emerging pharmacological strategies, specifically senolytics and senomorphics, assessing their capacity to restore cardiac function and attenuate atherosclerosis. Additionally, the utility of molecular biomarkers and diverse in vitro and in vivo models is analyzed More >